Description

6-Bromo-8-Methoxy-3-Nitroimidazo[1,2-A]Pyrazine is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant commercial importance for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular architectures. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new drug candidates, especially within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of complex drug molecules and novel APIs.
• Medicinal Chemistry Research: Used as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Process Development: Employed in the scale-up and optimization of synthetic routes for potential new therapeutics.
• Chemical Biology Probes: Can be utilized in the development of specialized probes for studying biological mechanisms and target identification.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Used in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name	6-Bromo-8-Methoxy-3-Nitroimidazo[1,2-A]Pyrazine
CAS No.	193614-80-1
Molecular Formula	C7H5BrN4O3
Molecular Weight	273.05 g/mol
Synonyms	6-Bromo-8-methoxy-3-nitroimidazo[1,2-a]pyrazine; Imidazo[1,2-a]pyrazine, 6-bromo-8-methoxy-3-nitro-; 3-Nitro-6-bromo-8-methoxyimidazo[1,2-a]pyrazine; 6-Bromo-8-methoxy-3-nitro-imidazo[1,2-a]pyrazine; 193614-80-1; 6-Br-8-MeO-3-NO2-Imidazo[1,2-a]Pyrazine
EINECS	Contact for details

Quality Control

Our 6-Bromo-8-Methoxy-3-Nitroimidazo[1,2-A]Pyrazine is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with each shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	Yellow to light brown powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.